BeiGene | Study to Investigate the Absorption, Metabolism, and Excretion of [14C]-Pamiparib in Participants With Advanced Cancer

⟵ Back to Search Results

Study to Investigate the Absorption, Metabolism, and Excretion of [14C]-Pamiparib in Participants With Advanced Cancer

Beigene Study ID

BGB-290-106

ClinicalTrials.gov ID

NCT03991494

EudraCT Number

2018-001156-36

Sex: All

Age: 18 Years / N/A

Study Protocol Statistical Analysis Plan

Sex: All

Age: 18 Years / N/A

Study Protocol Statistical Analysis Plan